Sweden· SE-20161129000198
Fosaprepitant Accord 150 mg Pulver till infusionsvätska, lösning
A medicinal product containing fosaprepitant, registered in Sweden by Accord Healthcare B.V..
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Fosaprepitant
- Manufacturer
- Accord Healthcare B.V.
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20161129000198
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fosaprepitant in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainFOSAPREPITANT ACCORD 150 MG POLVO PARA SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
- NorwayFosaprepitant accordAccord
- United KingdomFosaprepitant 150mg powder for solution for infusion vialsAmarox Ltd
- PolandIvemendMerck Sharp & Dohme B.V.
- GermanyFosaprepitant AmaroxAmarox Pharma Gmbh
- NetherlandsFosaprepitant Amarox 150 mg, poeder voor oplossing voor infusieAmarox Pharma B.V.
- United StatesfosaprepitantMylan Institutional LLC
- SwitzerlandIvemend
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Fosaprepitant Accord, Fosaprepitant Hikma
- Germany · Fosaprepitant Amarox, Fosaprepitant Hikma
- Spain · Fosaprepitant Accord, Fosaprepitant Hikma
- Finland · Fosaprepitant Accord
- United Kingdom (Northern Ireland) · Fosaprepitant Accord Healthcare, Fosaprepitant Amarox
- Iceland · Ivemend
- Italy · Fosaprepitant Accord, Fosaprepitant Hikma
- Liechtenstein · Ivemend
- Netherlands · Fosaprepitant Amarox
- Norway · Fosaprepitant Accord, Ivemend
- Portugal · Fosaprepitant Accord, Fosaprepitant Farmoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5678f263-9623-41bd-be5b-84a7b35b5a22 GET /v1/drugs/5678f263-9623-41bd-be5b-84a7b35b5a22?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL",
"SmPC"
],
"se_npl_id": "20161129000198",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20161129000198",
"product_doc_link": "https://docetp.mpa.se/LMF/Fosaprepitant%20Accord%20powder%20for%20solutionfor%20infusion%20SmPC_09001bee807a41a2.pdf"
}See everything about fosaprepitant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.